-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
What is HC Wainwright’s Forecast for TARS Q4 Earnings?
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities research analysts at HC Wainwright issued their Q4 2025 earnings per share estimates for Tarsus Pharmaceuticals in a report released on Wednesday, February 26th. HC Wainwright analyst O. Livnat anticipates that the company will earn ($0.06) per share for the quarter. HC Wainwright has a “Buy” […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities research analysts at HC Wainwright issued their Q4 2025 earnings per share estimates for Tarsus Pharmaceuticals in a report released on Wednesday, February 26th. HC Wainwright analyst O. Livnat anticipates that the company will earn ($0.06) per share for the quarter. HC Wainwright has a “Buy” […]
